Unregistered Submission
Pancreatic beta cell failure is central mechanism of obesity-induced type 2 diabetes. Authors of this paper claimed pharmaceutical usage of triple agonist (GLP1, GIP1 and glucagon) has potential to…
Pancreatic beta cell failure is central mechanism of obesity-induced type 2 diabetes. Authors of this paper claimed pharmaceutical usage of triple agonist (GLP1, GIP1 and glucagon) has potential to…
Not even descriptive morphometric information (like islet density, volume, alpha/beta ratio etc) is provided about islets!! They only showed simple islet staining from vehicle- and drug-treated of…
While 1nmol/kg/d of drug has no impact on BW gaining in ZDF-treated rats (Sfig8a), it substantially reduced fasting BG levels and moderately improved glucose tolerance (Sfig8b,c)! How would authors…